This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Accuray's (ARAY) CyberKnife S7 to Enhance Radiation Treatment
by Zacks Equity Research
Accuray's (ARAY) latest generation CyberKnife S7 System is expected to boost the cancer treatment capabilities of the Providence Swedish Radiosurgery Center.
Bruker (BRKR) to Advance in Lab Automation With New Buyout
by Zacks Equity Research
This strategic move positions Bruker (BRKR) to further strengthen its Project Accelerate 2.0 initiative, focusing on "Assays, Software, and Aftermarket."
AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment
by Zacks Equity Research
AngioDymics' (ANGO) new FDA-approved Auryon XL Catheter is likely to boost PAD treatment by eliminating access site complications in Atherectomy procedures.
BD (BDX) Collaborates With Hamilton to Benefit Researchers
by Zacks Equity Research
Becton, Dickinson and Company (BDX) partners with Hamilton to boost its portfolio of single-cell multiomics solutions, enabling researchers to perform more confident experiments.
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Acadia Healthcare (ACHC) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.
Universal Health (UHS) Up 5.3% in 6 Months: More Room to Run?
by Zacks Equity Research
Universal Health's (UHS) rising patient volumes and better pricing position the company well for growth.
Surmodics' (SRDX) New Device to Boost Its Thrombectomy Platform
by Zacks Equity Research
Surmodics (SRDX) new addition to its Pounce Thrombectomy Platform is recommended for use in vessels with a diameter between 2 mm and 4 mm for clot removal.
Dexcom (DXCM) Set to Solidify Its Business Throughout EMEA
by Zacks Equity Research
Dexcom (DXCM), opening a new manufacturing facility in the West of Ireland, is expected to boost production of rtCGM sensors and create employment.
McKesson (MCK) Set to Sell Canadian Rexall Pharmacy Group
by Zacks Equity Research
McKesson (MCK) is seeking buyers for the Canadian Rexall Pharmacy Group. The business is currently amid its second round of offers, with no set deadline for submissions.
Stryker's (SYK) Gamma4 Expansion Set to Boost Fracture Healing
by Zacks Equity Research
With the expansion of Gamma4, Stryker (SYK) is looking forward to strengthening its nailing system and solidifying its position as a leading choice in Orthopedic procedures.
PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction
by Zacks Equity Research
PacBio's (PACB) new offering, PanDNA kit, is likely to help researchers effectively extract DNA optimized for HiFi sequencing. This versatile Nanobind kit is expected to be available in February 2024.
Stryker's (SYK) New Tech Aims to Improve Surgeon's Efficiency
by Zacks Equity Research
Stryker's (SYK) Blueprint Mixed Reality Guidance system aims to benefit shoulder arthroplasty surgeons by improving efficiency and minimizing errors.
GE Healthcare (GEHC) Buys MIM Software to Boost Imaging Tools
by Zacks Equity Research
GE Healthcare (GEHC) is likely to enhance medical imaging capabilities and boost powerful AI solutions with the acquisition of MIM Software. Financial details are kept under cover.
Acadia Healthcare (ACHC) Inks JV to Better Serve Texas Residents
by Zacks Equity Research
Acadia Healthcare (ACHC) enters into a JV with Ascension Seton to expand the availability of inpatient behavioral beds across Austin and thereby, establish a solid footprint in the region.
Why Acadia (ACHC) is a Smart Addition to Your Portfolio Now
by Zacks Equity Research
Acadia Healthcare's (ACHC) top line is poised to gain from rising admissions and patient days.
Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?
by Zacks Equity Research
Here is how Acadia Healthcare (ACHC) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.
Here's Why Acadia Healthcare (ACHC) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Acadia Healthcare (ACHC) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Acadia Healthcare (ACHC) Opens Facility to Serve California
by Zacks Equity Research
Acadia Healthcare (ACHC) conducts a ribbon-cutting ceremony for its Indio-based acute care facility, which aims to cater to the dire need for high-quality behavioral healthcare services in the region.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems are part of the Zacks Industry Outlook article.
5 Hospital Stocks to Watch Amid Promising Industry Trends
by Kaibalya Pravo Dey
Rising patient volumes and technological advancements for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving operating efficiency.
Why Acadia Healthcare (ACHC) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Evaluating Acadia Healthcare's (ACHC) Future View: Hold or Fold?
by Zacks Equity Research
Acadia Healthcare's (ACHC) top line is poised to capitalize on increasing patient days and bed capacity.
Are Options Traders Betting on a Big Move in Acadia Healthcare (ACHC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
Here's Why Acadia Healthcare (ACHC) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.